Pimafucort cream 15g

Product form, composition and packaging Cream for external use from white to white with a yellowish tinge.

1 g

natamycin

10 mg

neomycin (as sulfate)

3500 units

hydrocortisone micronized

10 mg

sodium citrate - 14 mg, emulsifier F - 115 mg, sorbitan stearate - 30 mg, cetyl ether wax - 60 mg, cetiol V - 150 mg, macrogol stearate 100 - 20 mg, methyl parahydroxybenzoate - 2 mg, propyl parahydroxybenzoate - 0.5 mg, purified water - up to 1 g.

15 g - aluminum tubes (1) - cardboard packs. 15 g - plastic tubes (1) - cardboard packs.

Name ENG

PIMAFUCORT

Clinical and pharmacological group

Drug with antibacterial, antifungal and anti-inflammatory action for external use

ATX code

Hydrocortisone in combination with antibiotics

Dosage

10mg / g + 10mg / g + 3500 units / g x 15g

Structure

1 g: - Natamycin 10 mg - Neomycin (in the form of neomycin sulfate) 3500 U - Micronized hydrocortisone 10 mg Excipients: Sodium citrate 14.0 mg, emulsifier F 115.0 mg, sorbitan stearate 30.0 mg, wax cetyl ether 60.0 mg, cetiol V 150.0, macrogol stearate 100 20.0 mg, methyl parahydroxybenzoate 2.0 mg, propyl parahydroxybenzoate 0.50 mg, purified water to 1000.0 mg.

Indications

Dermatoses amenable to glucocorticosteroid therapy, complicated by a secondary bacterial and / or fungal infection (especially caused by Candida fungi).

INN / Active ingredient

hydrocortisone, natamycin, neomycin (as sulfate)

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Contraindications

hypersensitivity to the components of the drug Pimafukort

tuberculosis of the skin, skin manifestations of syphilis, viral skin infections, skin post-vaccination reactions, open wounds, ulcers

acne, rosacea, ichthyosis

anogenital itching, skin tumors.

Carefully.

Used with caution in tuberculosis (systemic damage)

in children under the age of 1 year

in patients with a history of indications of the defeat of the IX pair of craniocerebral neoplasms against the background of the use of aminoglycosides.

In the presence of perforation of the tympanic membrane and direct exposure of the middle ear to neomycin, there is a risk of ototoxicity.

Specifications

Category

Regenerating agents

Scope of the drug

Leather

Release form

Cream

Manufacturer country

Italy

Package quantity, pcs

one

Scope of application

Dermatology

Minimum age from

1 year

Way of introduction

On the skin

Vacation conditions

Without recipe

Brand name

ASTELLAS

The amount of the dosage form in the primary package

15 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

D07CA01 Hydrocortisone, in combination with antibiotics

Dosage form

Cream for external use

Packaging

Cardboard box

Expiration date in days

1095

The target audience

Adult

Package weight, g

twenty

Mode of application

:

For adults and children, Pimafukort is applied to the affected skin 2-4 times a day.

The duration of treatment is determined individually, taking into account the nature of the disease, the course of treatment usually does not exceed 14 days.

< br> In children, the drug should be applied to limited areas of the skin, do not use occlusive dressings.

If there is no improvement in the condition in children and adults after 14 days, you should consult a doctor.

< br> In the form of a cream, the drug is recommended for the treatment of acute and subacute dermatoses, incl.

accompanied by weeping.

The ointment is intended for the treatment of subacute and chronic dermatoses, especially in the presence of severe dry skin, lichenification, seborrhea, or in cases where the occlusive properties of the ointment are required

Pharmaco-therapeutic group

:

Topical glucocorticosteroid + aminoglycoside antibiotic + antifungal agent

Dosage (volume) of the substance in the preparation

:

natamycin 10 mg, neomycin (in the form of sulfate) 3500 IU, micronized hydrocortisone 10 mg